OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Instagram Outage Disrupts Thousands of U.S. Users 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
NEW YORK, Nov. 02, 2016 -- Nicholas Lange, Associate Professor of Psychiatry at Harvard Medical School, has been selected to join the Education Board at the American Health Council. He will be sharing his knowledge and expertise in the areas of Biostatistics, Brain Imaging, and Autism Research.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/dab56ef2-6a2d-4d19-a802-b4e01dfd3ab3
Dr. Lange’s continuing contributions to science over more than 30 years have been in the development and application of novel methodology for longitudinal and clustered data to investigate typical and atypical human and non-human brain development in psychotic disorders, spatial patterns of brain cells, and brain-behavior associations in autism.
Dr. Nicholas Lange, also a Biostatistician at McLean Hospital, has led and continues to lead multi-disciplinary teams of biostatisticians and other scientists that have made, and will continue to make, significant gains in the basic, translational, and clinical science of the developing human brain. McLean Hospital is the largest psychiatric affiliate of Harvard Medical School and a leader in scientific medical research and medical education.
Inspired by his early work with both children and adults with autism, Dr. Lange redirected his research program in the psychotic disorders to conduct various research studies of people on the autism spectrum. It is his continuing desire to foster high-quality biostatistical thinking, methods, and practice to further our understanding of the diagnosis, treatment, course, and outcome in autism and other mental disorders, with the overarching goal of improving the lives of individuals with mental illnesses and changing policy to increase funding from local, state, national, and international governments, institutions, private foundations, and private donations.
Dr. Lange regularly conducts multisite studies of brain development and concomitant psychophysical correlates in autism and searches for clinically relevant candidate intermediate phenotypes of the disorder. He has conducted a clinical trial of two early intervention programs in autism and an incipient clinical trial of ECT treatment for the elderly with major cognitive deficits and extreme anxiety.
Dr. Lange credits his success to his vision, persistence, hard work, and mentors who have taught and helped inspire him to reach his personal and professional goals. He is honored to have contributed to scientific knowledge regarding biology-based identification of those individuals who have been diagnosed with autism. Dr. Lange has been published in many theoretical and applied statistics and medical journals, opinion pieces (as in Nature on Imaging Autism), and a variety of editorials.
His goals over the next five years include making major discoveries in brain-mind-behavior associations and causes in autism that significantly increase clinical utility and effectiveness for the individual with autism.
Dr. Lange’s many awards and honors include the Robert B. Reed Prize for Outstanding Scholarship, Harvard Biostatistics; Invited Article of the Year, Journal of the American Statistical Association; Invited Paper, Royal Statistical Society in (London), the first article on functional magnetic resonance imaging (fMRI) published in the statistical literature; and Certificate of Service and Appreciation, Journal of the American Academy of Child and Adolescent Psychiatry. He was appointed to a National Institutes of Health (NIH) Scientific Advisory Panel to evaluate the sites chosen for their nationwide early autism research network. Dr. Lange has also been included in the Marquis Who’s Who in Science and Engineering and the Marquis Who’s Who in America.
He is a member of the International Society for Autism Research. He also works with Autism Speaks and the National Institutes of Health.
Dr. Lange received his MS in Computer Science from the University of Massachusetts Amherst in 1981 and his PhD in Biostatistics from the Harvard University School of Public Health in 1986.
Dr. Nicholas Lange’s greatest personal achievement has been raising his children Sarah and Nick. He finds great joy in spending time with them and his four adorable granddaughters - Ella, Adeline, Isabel, and Meghan – and his amiguita Margarita. In his free time, Dr. Lange enjoys playing classical and rock guitar, traveling, learning more Spanish, philosophy and the philosophy of statistics, and early practice of Eastern Christianity.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]
